Generex Biotechnology Corp. | Balance Sheet
Fiscal year is August-July. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,709.00
3,269.50
750.00
16.90
2,879.20
1,046.40
Inventories
-
-
-
-
10.00
12.10
Other Current Assets
98.30
201.30
51.20
8.10
21.90
96.30
Total Current Assets
1,807.30
3,470.80
801.20
25.00
2,911.10
1,188.20
Net Property, Plant & Equipment
85.40
5.30
2.90
1.30
0.60
31.50
Total Investments and Advances
640.80
-
-
-
4,237.80
2,168.20
Intangible Assets
2,319.40
2,046.40
1,430.00
-
2,937.20
3,211
Other Assets
-
-
-
-
7.80
7.80
Total Assets
4,852.90
5,522.50
2,234.10
26.30
10,094.50
6,606.90
ST Debt & Current Portion LT Debt
617.70
-
-
50.00
13,738.10
Accounts Payable
7,661.20
-
-
-
10,172.60
Other Current Liabilities
224.80
8,257.80
8,018.30
8,950.90
-
Total Current Liabilities
8,503.70
8,257.80
8,018.30
9,000.90
23,910.80
Other Liabilities
6,490.50
3,354.70
2,506.10
2,242.30
66,060.00
Total Liabilities
14,994.20
11,612.50
10,524.40
11,243.10
89,970.80
Common Equity (Total)
10,141.30
6,090.10
8,290.30
11,216.90
74,357.80
Total Shareholders' Equity
10,141.30
6,090.10
8,290.30
11,216.90
74,357.80
Total Equity
10,141.30
6,090.10
8,290.30
11,216.90
79,876.20
Liabilities & Shareholders' Equity
4,852.90
5,522.50
2,234.10
26.30
10,094.50
Accumulated Minority Interest
-
-
-
-
5,518.50
Preferred Stock (Carrying Value)
-
-
-
-
0.00
About Generex Biotechnology
View Profile
